Health Care: Drugs

Biogen Idec Inc (BIIB: NASDAQ)

$342.58 -3.26 | -0.94%
08/20/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 5.81B 4.38B 5.05B 4.72B
Cost of Sales 668.93M 382.05M 316.41M 255.09M
Gross Operating Profit 5.14B 4.00B 4.73B 4.46B
Selling, General, and Administrative Expenses 1.80B 1.28B 1.37B 1.29B
Research & Development 1.44B 1.33B 1.22B 1.25B
Operating Income before D & A (EBITDA) 1.90B 1.38B 2.14B 1.92B
Depreciation & Amortization 531.74M 365.65M 358.93M 354.10M
Interest Income 8.20M 29.50M 19.20M 22.30M
Other Income - Net 1.12B 841.36M -35.74M -5.18M
Special Income / Charges 547.00K 0.00 0.00 -489.95M
Total Income Before Interest Expenses (EBIT) 2.50B 1.89B 1.74B 1.27B
Interest Expense 31.90M 36.50M 33.00M 36.10M
Pre-Tax Income 2.46B 1.85B 1.71B 1.23B
Income Taxes 601.01M 470.55M 444.53M 331.33M
Minority Interest 0.00 0.00 32.26M -106.70M
Net Income From Continuing Operations 1.86B 1.38B 1.27B 898.57M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 1.86B 1.38B 1.27B 898.57M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 1.86B 1.38B 1.23B 1.01B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.86B 1.38B 1.29B 1.22B
Preferred Dividends
Net Income Available To Common 1.86B 1.38B 1.27B 898.57M
Basic EPS from Continuing Ops. 7.86 5.80 5.09 3.98
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 7.86 5.80 5.09 3.98
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 7.86 5.80 5.09 3.98
Basic Normalized Net Income/Share 7.86 5.81 5.17 5.40
EPS fr Continuing Ops. 7.81 5.76 5.04 3.94
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 7.81 5.76 5.04 3.94
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 7.81 5.76 5.04 3.94
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
7.81 5.77 5.12 5.35
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with BIIB

Latest BIIB Headlines from TheStreet

More Financial News for BIIB

Press Releases for BIIB

See All Press Releases

Partner Headlines for BIIB

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter